Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma.
about
Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of the FDA and ASCO ...... ry Tract Urothelial Carcinoma.
@en
Comparison of the FDA and ASCO ...... ry Tract Urothelial Carcinoma.
@nl
type
label
Comparison of the FDA and ASCO ...... ry Tract Urothelial Carcinoma.
@en
Comparison of the FDA and ASCO ...... ry Tract Urothelial Carcinoma.
@nl
prefLabel
Comparison of the FDA and ASCO ...... ry Tract Urothelial Carcinoma.
@en
Comparison of the FDA and ASCO ...... ry Tract Urothelial Carcinoma.
@nl
P2093
P2860
P356
P1476
Comparison of the FDA and ASCO ...... ry Tract Urothelial Carcinoma.
@en
P2093
Bohyun Kim
Boram Song
Gilhyang Kim
Kyung Chul Moon
Yul Ri Chung
P2860
P304
P356
10.4132/JPTM.2016.07.12
P577
2016-10-10T00:00:00Z